WaveCheck

WaveCheck is a painless, non-surgical clinical technique aimed at transforming chemotherapy response monitoring for women with breast cancer. It combines conventional frequency (5-10 MHz) ultrasound with new software to detect responses to chemotherapy in breast cancer tissues. By making better, more accurate information available about patient response to chemotherapy treatment in weeks, not months, WaveCheck creates greater transparency through dialogue between patient and their doctors.

Inventors

  • Dr. Gregory Czarnota, Sunnybrook Research Institute
  • Professor Michael Kolios, Ryerson University

MaRS Innovation Contact

Fazila Seker